While chimeric antigen receptor (CAR) T-cell therapy has demonstrated its ability to produce responses in refractory tumors, many challenges remain with the therapies. Precision’s Phil Cyr discusses some of these challenges as well as questions and research that remain to be answered.
Read the full article here!
The November Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
The COVID-19 pandemic led to an increase in depression and anxiety, along with an increase in opioid use and overdose while emergency needs for COVID-19 vaccination and treatment captured the health community’s attention, and the focus on substance abuse treatment faltered. As a result of the worsening mental health issues and decreased attention to substance use, the United States saw an increase in alcohol and opioid use, resulting in additional comorbidities and deaths. Precision’s Cynthia Miller and Maureen Hennessey discuss actions pharmaceutical companies can take as well as policy changes they should support to help address the crisis.
The October Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
Congratulations to Maureen Hennessey for being named to the 2022 PharmaVoice100, as a DE&I Champion! Maureen has been fearless in her dedication and pursuit to address the gaps that exist in today’s healthcare system that lead to medication non-adherence and impact social determinants of health. She continues to inspire all of us by pushing the boundaries on what patient-centric care could and should be for all populations. Check out Maureen’s complete profile in PharmaVoice below: Congratulations to Maureen Hennessey for being named to the 2022 PharmaVoice100, as a DE&I Champion! Maureen has been fearless in her dedication and pursuit to address the gaps that exist in today’s healthcare system that lead to medication non-adherence and impact social determinants of health. She continues to inspire all of us by pushing the boundaries on what patient-centric care could and should be for all populations. Check out Maureen’s complete profile in PharmaVoice here!
Check out our September Events Calendar, and stay up to date with all of the upcoming and on-demand Precision events and thought leadership! Download Now!
NEW WHITE PAPER!
Earlier this year, Precision Value & Health, in association with Precision ADVANCE, hosted an in-depth, live roundtable: The Future Treatment and Access Landscape for Cell and Gene Therapies— assembling the perspectives of:
Dan Vanderpoel, Executive Vice President of PRECISIONvalue, and Dominic Galante, MD, Precision’s Chief Medical Officer, co-moderated the discussion covering a wide range of topics, with the group providing insights, first-hand examples and looks ahead.
And now…you can “listen in” to this exclusive panel of diverse perspectives in our new white paper, summarizing the complete roundtable discussion along with providing key takeaways and future considerations for manufacturers.
Don’t miss out on your chance to grab a free copy of this valuable resource— just click here for yours!
Don’t miss any of our upcoming Precision Value & Health Events! Download the events calendar and stay up to date with all our thought leadership. Download Now!
In partnership with Precision VH, this webinar is a virtual panel discussion where experts will describe and debate the contributions that Medical Affairs can make to early R&D (preclinical through Ph-IIb).
Congratulations to Suepattra May-Slater and the PRECISIONheor team for their contributions to a impactful study just published in the journal MMS Policy and Practice. The paper, entitled: “Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method” outlines the challenges in truly capturing the economic burden of cancer for both patients and their caregivers.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
